查找临床试验
已按「系统性红斑狼疮」检索，对应国际通用词 systemic lupus erythematosus
共找到 12 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 10:03，每 5 分钟自动同步Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
Sweden
年龄 18 Years – 不限
Karolinska Institutet
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
United States
年龄 18 Years – 100 Years
Terry L. Wahls
Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation
France
年龄 18 Years – 80 Years
University Hospital, Brest
VIBRANT: VIB4920 for Active Lupus Nephritis
United States
年龄 18 Years – 不限
National Institute of Allergy and Infectious Diseases (NIAID)
Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone
Netherlands
年龄 16 Years – 70 Years
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
United States、Bulgaria、Canada、China、Czechia 等 12 国
年龄 18 Years – 75 Years
EMD Serono Research & Development Institute, Inc.
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
United States
年龄 18 Years – 80 Years
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
United States
年龄 18 Years – 75 Years
Viatris Innovation GmbH
Anifrolumab Pregnancy Study
United States
年龄 18 Years – 130 Years
AstraZeneca
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
France
年龄 18 Years – 70 Years
University Hospital, Strasbourg, France
Alnuctamab for Refractory SLE (LATTE Study)
United States
年龄 18 Years – 60 Years
Icahn School of Medicine at Mount Sinai
CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
United States
年龄 18 Years – 不限
CorEvitas